From industrializing mRNA manufacture to the implications of a potential IP waiver on COVID-19 vaccine production, hear from the experts in our free webinar this week.
Podcast: Pharma insiders clash over COVID IP waiver
Guests from IFPMA, Knowledge Ecology International and Gowling WLG debate the necessity of waiving IP rights to COVID-19 vaccines May 19 2021
Earlier this month, US President Joe Biden shocked the pharmaceutical
industry with his declared support for an intellectual property waiver for
COVID-19 vaccines.
In this special podcast, reporter Charlotte Kilpatrick moderates
a debate between Komal Kalha, lead for IP and trade policy at the International
Federation of Pharmaceutical Manufacturers & Associations; James Love, director of Knowledge Ecology International; and Gordon
Harris, partner at Gowling WLG.
In this heated debate, guests discuss the flexibilities of